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Abstract
Neonatal hyperbilirubinemia targets specific brain regions and can lead to kernicterus. One of the most debilitating symptoms
of kernicterus is dystonia, which results from bilirubin toxicity to the globus pallidus (GP). Stem cell transplantation into the
GP to replace lost neurons and restore basal ganglia circuits function is a potential therapeutic strategy to treat dystonia in
kernicterus. In this study we transplanted human medial ganglionic eminence (MGE)-like neural progenitor cells (NPCs) that
we differentiated into a primarily gamma-aminobutyric acid (GABA)ergic phenotype, into the GP of non-immunosuppressed
jaundiced (jj) and non-jaundiced (Nj) rats. We assessed the survival and development of graft cells at three time-points post-
transplantation. While grafted MGE-like NPCs survived and generated abundant fibers in both jj and Nj brains, NPC survival
was greater in the jj brain. These results were consistent with our previous finding that excitatory spinal interneuron-like
NPCs exhibited a higher survival rate in the jj brain than in the Nj brain. Our findings further support our hypothesis that
slightly elevated bilirubin levels in the jj brain served as an antioxidant and immunosuppressant to protect the transplanted
cells. We also identified graft fibers growing toward brain regions that receive projections from the GP, as well as host fibers
extending toward the graft. These promising findings suggest that MGE-like NPCs may have the capacity to restore the circuits
connecting GP and other nuclei.
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Introduction
Neonatal jaundice due to elevated blood bilirubin levels
occurs in up to 85% of newborns1. When bilirubin levels
exceed the binding capacity of albumin, excess free uncon-
jugated bilirubin enters the brain where it targets specific
nuclei, including the globus pallidus (GP), subthalamic
nucleus, inferior colliculus, hippocampus, and cerebellum2,3.
Free bilirubin is toxic and can lead to kernicterus, which is a
devastating and permanent neurological syndrome. Cur-
rently, there is no effective cure for kernicterus. Because it
strikes during infancy, affected individuals and their families
are subjected to a lifetime of dependency on caregivers.
Among the most debilitating symptoms of kernicterus is
painful dystonia resulting from damage to the GP2. The GP
is a key relay nucleus in the basal ganglia pathway. Due to
the toxic effects of bilirubin in the GP, we believe that tar-
geting this nucleus with neuronal stem cells to replace the
lost neurons and reconstruct basal ganglia circuit function is
a logical therapeutic approach for treating dystonia in
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kernicterus. Research into neonatal jaundice and kernicterus
has been facilitated by the use of the Gunn rat model4.
Homozygous jaundiced Gunn rats (jj) rats lack the gene for
uridine diphosphate glucuronosyl transferase, the enzyme
responsible for bilirubin conjugation and elimination. This
leads to hyperbilirubinemia5. Using this model, we recently
reported that excitatory spinal cord interneuron-like neural
progenitor cells (NPCs) had a greater survival rate in the jj
brain than in the non-jaundiced (Nj) brain6.
The goal of the current study was to develop and test more
GP-like NPCs in the Gunn rat model. With the exception of
*5% that are cholinergic, most of the neurons in the GP are
gamma-aminobutyric acid (GABA)ergic. Among these
GABAergic neurons, at least 50–60% co-express parvalbu-
min (PV)7–9, while a smaller population expresses preproen-
kephalin (PPE)8. There are multiple embryological origins of
GP neurons. Most (*70%) are derived from the caudoventral
portion of the medial ganglionic eminence (MGE), while the
lateral ganglionic eminence generates about 25% and the pre-
optic area gives rise to the other 5%9. We chose NPCs derived
from the WA09 human embryonic stem cell line (hESC) and
differentiated into MGE-like NPCs. Upon differentiation,
these cells phenotypically resemble GABAergic neurons in
the basal ganglia. These cells were transplanted into the GP of
jj Gunn rats and their non-jaundiced (Nj) littermates, and
assessed for graft survival and development.
Materials and Methods
Propagation and Preparation of Human NPCs for
Transplantation
Pluripotent stem cell culture. WA09 human embryonic stem
cells10 were maintained in an undifferentiated state by cul-
ture on Matrigel in mTeSR media (Corning 354277, Corn-
ing, Tewksbury, MA, USA). Cells were passaged every 4
days with ReLeSR reagent (Stem Cell Technologies 05872,
Stem Cell Technologies, Vancouver, BC, Canada).
Pluripotent stem cell aggregation and differentiation. Embryoid
body (EB) formation and culture were performed in defined
serum-free knockout serum replacement media (KOSR)11
consisting of KO-MEM, 20% knockout serum replacement,
glutamine, non-essential amino acids, penicillin-streptomycin
(all from Thermo Scientific, Waltham, MA, USA) supple-
mented with the following small molecules and growth fac-
tors: fibroblast growth factor (FGF), Rho-associated, coiled
containing protein kinase inhibitor (ROCKi [Y27632]),
LDN193189, SB431542, IWP3, fibroblast growth factor 8a
(FGF8A), smoothened agonist (SAG), and DAPT. Cells were
aggregated via centrifugation using AggreWell plates (Stem
Cell Technologies) to a defined EB size of 2100 cells. After
overnight culture of the cells in AggreWell plates in 37oC, 5%
CO2, EBs were collected. EBs were subsequently cultured in
ultra-low attachment plates in supplemented KOSR media
with small molecules, based on previous studies12. EBs were
cultured at 37C in 5% CO2. Half of the media was replaced
daily. On days in which the small molecule formula was
changed, EBs were collected with strainers (37 mm pore size,
Stem Cell Technologies ) and moved to the appropriate
media. After day 18 of differentiation, EBs were transferred
to neural maintenance media NTD2 (neurobasal media), 1X
B27, 1X insulin-transferrin-selenium (ITS), 1X pyruvate, 0.5
mg/ml cAMP, 0.4 mg/ml ascorbic acid, 25 mM BME, 25 mM
glutamine (all from Thermo Scientific) and 10 ng/ml each
brain-derived neurotrophic factor (BDNF), glial cell line-
derived neurotrophic factor (GDNF), ciliary neurotrophic
factor (CNTF), insulin-like growth factor (IGF)-1 (R&D Sys-
tems, Minneapolis, MN, USA).
Dissociation of embryoid bodies. EBs were collected on day 20
to 22 and placed into GentleMACS dissociation reagent (Mil-
tenyi, Auburn, CA, USA) and dissociated at 37oC for 20
minutes, with gentle hand pipetting after 10 minutes. Disso-
ciated cells were passed through a strainer, collected in NTD2
media and counted. For continued culture, cells were plated
onto laminin coated coverslips in NTD2 media and cultured at
37C in 5% CO2. For injection, cells were resuspended at
20,000 cells per 2.5 ml in Matrigel with NTD2 media supple-
mented with 30 ng/ml each BDNF, GDNF, CNTF, IGF-1.
Animals
Male and female Gunn rats used in this experiment were
bred in the University of Kansas Medical Center’s (KUMC)
colony by pairing homozygous jj males and heterozygous Nj
females. Rats lived with their mothers and siblings before
and after surgery and were weaned at 28 days of age (P28).
Animals were housed in a temperature-controlled (23–25C)
and humidity-controlled (45–50%) room maintained on 12/
12-h light/dark cycles with food (Teklad laboratory animal
diets 8604; Envigo, Madison, WI, USA) and water available
ad libitum. All experimental procedures were conducted in
accordance with the Guide for the Care and Use of Labora-
tory Animals. The study was approved by the University of
Kansas Medical Center’s Institutional Animal Care and Use
Committee (IACUC).
Bilirubin Level Measurement
Total serum bilirubin (TSB) levels of all jj rats were mea-
sured at postnatal day 17 (P17). For each animal, about 50 ml
of blood was taken and the TSB concentration was deter-
mined using a Leica Unistat bilirubinometer (Reichert Inc.,
Depew, NY, USA). Bilirubin levels in Nj rats were below the
limit of detection of the bilirubinometer.
Surgery
At 21 days of age (P21), rats were anesthetized with isoflur-
ane (3–4% for induction and 2–2.5% for maintenance with
oxygen) and placed in a stereotaxic frame (Kopf, Tujunga,
Yang et al 655
CA, USA). A small hole on the skull was drilled over the GP
using stereotaxic coordinates from a developing rat brain
stereotaxic atlas13. Coordinates were 5.3 mm anterior and
2.8 mm lateral from the interaural midpoint. A 26-gauge,
10-ml Hamilton microsyringe was lowered to a depth of
5.0 mm from the brain surface and NPCs suspended in
Matrigel (20,000 in 2.5 ml) were injected into the GP uni-
laterally at a flow rate of 0.5 ml/min. The needle was left in
place for an additional 5 min to prevent cell efflux and then
slowly removed. In order to compare time course and
regional influence of cell development, a subgroup of jj rats
received bilateral NPCs: one side in the striatum (coordi-
nates: anterior-posterior: 6.5 mm, medial-lateral: 2.8 mm,
dorsal-ventral: 5.0 mm), and the other side in the GP. After
surgery, the scalp was sutured and the rat was returned to its
cage for recovery. All rats received ketoprofen 5 mg/kg
subcutaneously for 3 days. As planned, an immunosuppres-
sant was not used in this experiment.
Immunohistochemistry and
Immunocytochemistry
At 3 weeks post-cell transplantation (P42 or P43), rats were
deeply anesthetized with isoflurane and transcardially per-
fused with ice-cold phosphate-buffered saline (PBS) fol-
lowed with 4% paraformaldehyde (PFA; Sigma-Aldrich,
St. Louis, MO, USA). Brains were removed and cryopro-
tected in 30% sucrose PBS solution prior sectioning for
immunohistochemistry (IHC) analyses. Subgroups of
double-grafted jj rats were only allowed to survive 3 or 10
days after NPC grafting. Coronal sections containing the
graft and the GP were cut at 30 mm with a cryostat (Leica
CM3050 S). All sections were processed with standard float-
ing section methods. Every sixth section was stained with
mouse monoclonal antibody specific for human species
cytoplasmic marker, STEM121 (1:500; Cellartis-Clontech,
Mountain View, CA, USA), to identify grafted human cells
and alternatively double stained with the following antibo-
dies: rabbit anti-human Ku80 (1:500; ABC am, Cambridge,
MA, USA) for human cell nuclei, rabbit anti-parvalbumin
(PV, 1:200; Pyroxenitic, Rosemont, IL, USA) or goat-anti-
PV (1:500; SantaCruz, Dallas, TX, USA) to identify graft
cells expressing PV, rabbit anti-proenkephalin (PENK,
1:1000; LifeSpan BioSciences, Seattle, WA, USA) for graft
or host cells expressing PPE. A further set of 1:6 series
sections was processed for double staining of mouse anti-
STEM123 (1:300; specific for human glial fibrillary acidic
protein (GFAP); Cellartis-Clontech) and Ku80. Extra cul-
tured cells that were not used for transplantation were plated
onto laminin and fixed after 30 min or 6 days of continued
culture; immunocytochemistry (ICC) was performed to
identify the cell properties. The following antibodies were
used for ICC: mouse immunoglobulin G (IgG)2A anti-
glutamic acid decarboxylase 6 (GAD-6, 1:100; Develop-
mental Studies Hybridoma Bank, University of Iowa, Iowa
City, IA, USA), rabbit anti-bIII-tubulin (1:200; ECM
Bioscience, Versailles, KY, USA), goat-anti-PV (1:500;
SantaCruz), rabbit anti-proenkephalin (PENK, 1:1000; Life-
Span BioSciences, Seattle, WA, USA), and mouse anti-
STEM123 (1:300; Cellartis-Clontech). Immune reactions
were visualized by corresponding secondary antibody label-
ing: goat anti-mouse IgG (HþL) Alexa Fluor 488 (1:2,000;
Invitrogen, Waltham, MA, USA), goat anti-rabbit Alexa
Fluor 555 (1:2000; Invitrogen), cyanine 3 (Cy3) donkey
anti-goat IgG (1:200; Jackson Immuno Research, West
Grove, PA, USA), goat anti-mouse IgG2A Alexa Fluor
594 (1:1000; Invitrogen).
Quantification and Statistics
All sections were examined under a fluorescence micro-
scope (Nikon Eclipse 80i; Nikon, Melville, NY, USA) and
analyzed with CellSens Standard (Olympus, Center Valley,
PA, USA) or NIS-Elements AR (Nikon) software. Images
(2, 4, 10, and 20) of the grafted areas were used.
Based on the STEM121 and Ku80 double labeling, the
numbers of viable transplanted cells were manually
counted with CellSens or NIH ImageJ (NIH, Bethesda,
MD, USA) independently by two people. The mean was
multiplied by 6 to estimate the total number of viable cells.
The migration distances of grafted cells from the graft tract
and the length of outgrowth axons were measured with
CellSens Standard or NIH ImageJ based on the images of
10 magnification. Cell survival rates between groups
were analyzed using analysis of variance or Student’s t test
(when there were only two groups to compare), and Pear-
son’s product moment correlation was used for the correla-
tion between bilirubin levels and graft cell survival rates
(SigmaStat 4.0, Systat Software Inc., San Jose, CA, USA).
Statistical significance was set at p < 0.05. All data are
shown as mean + standard error of the mean.
Results
Characteristics of the hESC-derived MGE-like NPCs
Cells cultured for 30 min or 6 days after transplantation were
examined with ICC in vitro to identify their neurochemical
phenotype. The results indicated that a large proportion of
cells were GABAergic, as assessed by expression of GAD-6
in both 30 min and 6 days culture. Cells in which colocaliza-
tion of GAD-6 and bIII-tubulin were identified were
abundant; some cells also co-expressed GAD-6 and PV, or
GAD-6 and PENK, indicating cells differentiated into MGE
GABAergic neuron-like phenotypes. In cells that were cul-
tured for 6 days after EB dissociation, rich, extended long
fibers were observed (Figure 1). ICC to detect GFAP (using
STEM123 antibody) showed that * 45% of the cells differ-
entiated into astrocytes. ICC to detect acetyltransferase was
negative, suggesting no cholinergic cells in the culture (data
not shown).
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Survival of the MGE cell-like NPCs 3 Weeks
Post-Transplantation
Surviving grafts were identified in brains of all transplanted
rats. Cell survival rate was calculated as a percentage of the
number of Ku80-ir nuclei surrounded by or apposite to
STEM121-ir cells to the total number of cells injected. Cell
survivability 3 weeks post-transplantation was 2.7%
(527+187) in the jj group and 0.8% (152+66) in the Nj
group. The survival rate of transplanted cells was signifi-
cantly greater in the jj brain than in the Nj brain (T¼53.0,
p¼0.026) (Figure 2). IHC for STEM123 and Ku80 labeling
did not identify cells expressing STEM123 in the graft of
either jj or Nj brains (data not shown).
Cell Distribution and Neurite Outgrowth 3 Weeks
Post-Transplantation
The anterior-posterior distance of transplanted cells’ distri-
bution was defined by the presence of cells stained with both
STEM121 and Ku80. The cell distribution in the jj group was
1620+167.6 mm and 930+142.6 mm in the Nj group. Most
of the grafted cells were located within a short distance (50–
100 mm) of the injection track. Cell clusters were usually
observed at the interface of the graft tract and the host tissue.
Depending on the site of the injection tract, small groups or
single cells spread in a wide range. Grafted cells were
identified mainly in the GP and internal capsule (ic), but
some cells were located in the basal nucleus, stria terminalis
(ST), bed nucleus of the stria terminalis (BNST), the ventral
portion of the thalamus, and the lateral ventricle (lv). In the
dorsal and anterior parts of the graft, scattered cells could be
seen in the cerebral cortex, corpus callosum (cc), and stria-
tum (str). Necrotic cells were observed in both jj and Nj
Figure 1. MGE-like NPCs expressed GAD-6, PV, and PENK in culture. Photomicrograph showing most of the cells were GAD-6-ir and bIII-
tubulin-ir ((a): 30 min; (b): 6 days) indicating a GABAergic phenotype. GAD-6 and PV double labeling show a subgroup of GABAergic
neurons also expressed PV ((c): 30 min; (d): 6 days). GAD-6 and PENK double labeling indicated many GABAergic neurons were PENK-ir
cells ((e), 30 min; (f), 6 days). Scale bar: a–f, 50 mm; d, 100 mm. GABA: gamma-aminobutyric acid; GAD-6: glutamic acid decarboxylase-6;
MGE: medial ganglionic eminence; NPC: neural progenitor cell; PENK: proenkephalin; PV: parvalbumin.
Figure 2. Survival of grafted MGE-like NPCs in jj and Nj brain.
Grafted cell survival rate was significantly higher in jj brain than in Nj
brain. Without immunosuppressant, survival rate was 2.7% in jj, but
only 0.8% in Nj brain;
*indicates statistical significance (p<0.05).
jj: jaundiced; MGE: medial ganglionic eminence; Nj: non-jaundiced;
NPC: neural progenitor cell.
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brains, especially along the dorsal portion of the graft track.
There were more necrotic tissue and fewer surviving cells in
the Nj than jj brains (see Figure 3 (a–h) for representative
images of graft survival in jj and Nj brain).
Neuritic outgrowth was observed a greater distance from
grafts than cell distribution. In the jj group, neuritic out-
growth occurred primarily in an anterior-posterior distance
of 2070+61.5 mm. For the Nj group the distance was
1560+110.6 mm. Abundant fiber outgrowth was observed
from grafts in jj and Nj brains; usually the closer to the
injection site the denser the fibers. Most fibers were dis-
tributed in the GP and the ic. Fibers extending into the
BNST, the ST, reticular thalamic nucleus, lateral anterior
nucleus of the thalamus (VA), or ventral lateral nucleus of
the thalamus (VL) were frequently observed. In more
posterior sections, some fibers were found in the
entopeduncular nucleus or the lateral hypothalamic area.
When cells grew into the lateral ventricle, fibers were
observed in the septal area and fornix (Figure 3(j)). Mor-
phologically, a large population of grafted cells featuring
short, thick parallel fibers was identified. These were espe-
cially prevalent when cells distributed along the border of
the track and the host parenchyma (see Figure 3(d, h, k)).
We also frequently observed a number of long, thin fibers
from the GP/ic area, extending parallel medially and/or
ventrally toward the thalamus and subthalamic areas and
forming specific projection patterns; some of this type of
long fibers had semi-perpendicular collaterals (Figure
3(i,l)). Graft cells always extended their fibers toward
the host tissue. We observed no fibers extending across the
tract to the other side of the host parenchyma. Moreover,
very few long fibers projected laterally into the striatum.
Figure 3. Grafted MGE-like NPC survival and fiber outgrowth in jj and Nj brain 3 weeks post-transplantation. (a–h): IHC staining for
STEM121 and Ku80 confirmed grated cell survival along the injection track in the GP and ic area. Note that most of the surviving cells were in
the graft/host border, or migrated into the host parenchyma. Outgrowth fibers distributed densely near the host-tract interface. In both
brains, many short, parallel fibers can be found along the edge of the tract. (a–d): jj brain; (f–h): Nj brain (a and h are lower magnification to
show the location of the graft). (i): Neurons migrated away from the tract in the GP and striatum. Note that there were long fibers with
semi-perpendicular collaterals. (j): Cells that grew into the lateral ventricle generated long fibers projecting medially toward the septal area.
Long fibers extending into the corpus callosum can also be seen. (k): Graft in the GP/ic intersection. Short parallel fibers aggregated in the
dorsal edge of the track; thin, long fibers extended medially and ventrally to the thalamus. (l): Photo from the same plane as (k), ventromedial
side, showing long, thin projection fibers with semi-perpendicular collaterals growing into the thalamus and subthalamic areas. Scale bar: (a
and e), 200 mm, the others 100 mm. Arrows point to representative cells and fibers. GP: globus pallidus; ic: internal capsule; IHC:
immunohistochemistry; jj: jaundiced; MGE: medial ganglionic eminence; Nj: non-jaundiced; NPC: neural progenitor cell.
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Early Time Course of Graft Cells’ Survival
and Development – 3 days and 10 Days
Post-Transplantation
The survival and growth of MGE-like NPCs grafted into
striatum or GP of jj brains were measured 3 and 10 days
after transplantation. In the 3-day group, the cell survival
rate was 8.4% (1668+324) in the GP and 4.6%
(924+108) in the striatum. However, 10 days after grafting,
cell survivability reduced to 1.55% (300+159) in the GP
and 1.49% (297+9) in the striatum. Cell survivability was
significantly greater 3 days than 10 days post-transplantation
(F(1,4)¼27.78, p¼0.006). There was no difference between
graft sites (F(1,4)¼3.09, p¼0.154) nor was there an interac-
tion between time-point and graft site (F(1,4)¼3.81,
p¼0.123). Post-hoc analyses with the Holm–Sadako method
further revealed greater survival rates at 3 days compared
with 10 days in the GP (t¼5.1, p¼0.007), but not in the
striatum (t¼2.353, p¼0.078). Moreover, graft survival rate
was greater in GP than in striatum only at 3 days post-
transplantation (t¼2.792, p¼0.049) (Figure 4). Brain regions
where grafted cells distributed 3 days or 10 days post-
transplantation were similar to what we observed 3 weeks
post-transplantation. At these two early time-points, most
surviving cells were located inside the graft track, with few
cells having migrated into the host tissue. This was espe-
cially true 3 days post-grafting. Most cells that survived
inside the track were small and lacked cell processes. Single
cells or cell clusters which migrated into the host parench-
yma or aggregated in the host-graft border usually had fiber
outgrowth. Even at the 3-day time-point, there were long
fibers identified in the striatum and cc. At 10 days after
transplantation, a few short, thick, parallel fibers and some
long projections from the GP to the ic and the thalamus were
observed (Figure 5).
Bilirubin Level in jj Rats and its Correlation to
Cell Survival
TSB concentration was 13.81+0.39 mg/dl. Pearson product
moment correlation revealed no correlation between the
TSB and cell survival rates in the GP of jj rats (r¼0.391,
p¼0.263).
Parvalbumin Expression in Transplanted hESC-derived
MGE-like NPCs
IHC double labeling for PV and STEM121 revealed low
numbers of PV-ir grafted MGE-like grafts in the jj host
GP and striatum 3 days and 10 days post-transplantation.
Similarly, very few PV-ir graft neurons were found in
both jj and Nj brains 3 weeks post-transplantation. Most
of the PV-ir neurons were identified in the graft tract and
the size of the cells was relatively small. The number of
cells in tissue was much less than that in cell culture
(Figure 6).
PENK Expression in the Host Brain
Although ICC indicated substantial PENK-ir NPCs in the
cell culture, IHC of PENK and STEM121 double labeling
showed no definitive PENK-ir grafted neurons in the brain
at 3 days, 10 days, or 3 weeks after transplantation. Instead,
strong PENK-ir fibers and cells, originating from the host
tissue, aggregated and surrounded the graft in both jj and Nj
brains. Interestingly, at 10 days and 3 weeks post-
transplant, when the site of the graft was in or adjacent to
the GP, there were PENK-ir fibers extending from the GP
to the region where surviving grafted cells and fibers were
located. Three days after transplantation, PENK-expressing
cells appeared surrounding the track and graft, but the
labeling was not as strong as that in 10 days and 3 weeks.
In addition, there was a distinct zone with less PENK-ir
staining between the graft and the high PENK-expression
area. This zone was not observed in brains 10 days or 3
weeks after grafting (Figure 7).
Discussion
Our ultimate goal is to use cell therapy to ameliorate dysto-
nia in kernicterus by restoring GP and basal ganglia circuit
function. The NPCs we chose for transplantation were dif-
ferentiated into MGE-derived progenitors, the major origin
of GP neurons9. However, MGE progenitors have multiple
targets, and GP is not their only destination12,14. To identify
whether the characteristics of these cells met the basic
requirements for transplantation, we used ICC to co-label
GAD-6 and bIII-tubulin to validate the presence of
GABAergic neurons in culture. Using our method modified
Figure 4. MGE-like NPC survivability when grafted into striatum
or GP at 3 days or 10 days post-transplantation. Overall, cell sur-
vival rate was significantly greater at 3 days. At 3 days, graft survival
rate was greater for the GP than the striatum. Survival rate did not
differ between the GP and striatum at 10 days. Cell survivability was
maintained in a low yet stable rate from 10 days to 3 weeks post-
transplantation.
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from Kim12, the majority of the cells were GABAergic neu-
rons. ICC for GAD-6 and PV double staining further con-
firmed that a subgroup of GABAergic neurons also
expressed PV. This is important because up to 60% of neu-
rons of the GP are PV-expressing neurons8,9,15. Our result
was similar to what was previously reported12. We also
found many cultured cells that co-expressed GAD-6 and
PENK, a result that has not been documented before.
PENK-expressing GABAergic neurons exist in both GP and
striatum8,16.
Figure 5. Grafted MGE-like NPCs survived and grew neurites in jj brain at 3 days (a–h) and 10 days (i–n) post-transplantation. IHC of
STEM121 and Ku80 co-labeling showing many surviving cells in the tract, most of them had no cell process. Few cells attached to the host
tissue started to grow short fibers. (a–d): striatum. (e–h): GP. (d) and (h) are shown at higher magnification to show the cells remained in the
track. IHC of STEM121 and ku80 at 10 days post-transplantation indicated more cells migrated to the host parenchyma; these cells usually
had fiber outgrowth. The number of surviving cells was less at 10 days than at 3 days. (i–k): striatum; (l–n): GP. Necrotic cells were observed
at both 3 days and 10 days. Scale bar: (d, h) 50 mm, all the others 100 mm. Arrows point to representative cells and fibers.
GP: globus pallidus; MGE: medial ganglionic eminence; NPC: neural progenitor cell; str: striatum; GP: globus pallidus; IHC: immunohisto-
chemistry; jj: jaundiced; MGE: medial ganglionic eminence; NPC: neural progenitor cell; str: striatum.
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We found that WA09 cell line-derived MGE-like NPCs
survived at least 3 weeks post-transplantation without immu-
nosuppressant and formed neurites with extensive outgrowth
in the GP and its adjacent structures in jj and Nj rat brains.
Moreover, the graft survivability was significantly greater in
the jj brain. These findings agree with our previous study,
which showed that hESC-derived excitatory NPCs had a
greater survival rate when transplanted into jj than Nj brain6.
The hypotheses that slightly elevated bilirubin exerted anti-
oxidant17 and immunosuppressant18 effects that protected
graft survival were further supported by our current results.
It is notable that the survival rates of the excitatory spinal
interneurons grafted in the striatum (21% in jj and 12.4% in
Nj) in our previous study6 were much higher than the sur-
vival rates of the MGE-like NPCs (2.7% in jj and 0.8% in Nj)
grafted into the GP. While the cell type can play a role in
survivability, site of transplantation could also affect the
result. To clarify this possibility, we used a subgroup of jj
rats that received MGE-like NPC grafts in one striatum and
in the contralateral GP to compare the graft survival and
development at two very early time-points: 3 days and 10
days after transplantation. Taken together with our previous
results, we believe that cell type is a more important factor
for survivability than graft site at these time-points. The
main factor that influenced cell survival rate was the post-
graft time-point. It was not surprising that the survival rate
was higher at 3 days, since the immune response likely had
not reached its peak at this time-point. However, the survival
rate of the 10-day group was similar to that of the 3-week
group. This suggests that bilirubin may have mitigated an
immune response. TSB levels increase from P10 until they
reach a maximum around P15 or P16, at which time they
gradually decrease around P17 to P19 but remain higher in jj
rats even at D6019,20. Due to its immunosuppressant proper-
ties, slightly greater bilirubin levels may have contributed to
a comparable survival rate in the graft 10 days and 3 weeks
after the transplantation. In addition, the fact that graft sur-
vival rate was greater in the GP than that in the striatum 3
days, but not 10 days, post-transplantation further suggests a
protective effect of bilirubin, especially in this bilirubin-
sensitive part of the brain3,21.
The lack of correlation between TSB at D17 and NPC
survival rates suggests that TSB levels are a poor predictor of
graft survival. The low variability of TSB may have
Figure 6. PV expression in the grafted MGE-like NPCs. IHC labeling for PV and STEM121 indicating PV-ir grafted neurons in the GP,
striatum, and lateral ventricle at 3 days, 10 days, and 3 weeks post-transplantation. Most of the PV neurons were identified in the graft tract;
the percentage of PV-ir cells was less than in cell culture. (a–c): jj GP, 3 days post-transplantation; (d–f): Nj striatum, 10 days post-
transplantation; (g–i): jj ventricle, 3 weeks post-transplantation. Scale bar: 100 mm. Arrows point to representative cells. GP: globus
pallidus; IHC: immunohistochemistry; jj: jaundiced; MGE: medial ganglionic eminence; Nj: non-jaundiced; NPC: neural progenitor cell;
PV: parvalbumin.
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contributed to this lack of correlation. However, TSB does
not reflect the free bilirubin concentration in the brain20. The
fact that graft cells survived better in the jj brain suggests
that bilirubin played a necessary but not sufficient role in
graft survival. Although the strategy of not using immuno-
suppressant may have revealed a protective effect of biliru-
bin on graft survival, the overall survival rate was low. This
suggests that immunosuppressant may be necessary to
improve survival.
Graft cells and their fibers were identified by STEM121
and Ku80 IHC labeling. Although most of the cells were
preferentially located near the graft core area, many graft
cells migrated a greater distance. We found that when graft
cells attached to the ventricle walls, they usually survived
and grew abundant fibers (Figure 3(j)) perhaps due to nutri-
tion supplies from the cerebrospinal fluid and greater space
to grow. However, this conflicts with another report of worse
graft survival near the ventricle due to immune factors22.
Notably, in contrast to the condition 3 weeks after
transplantation in which most surviving cells were found
in the graft–host border or had migrated into host tissue,
there were more surviving cells inside the graft track at two
earlier time-points (especially 3 days). Fewer cells migrated
into the host tissue. The cells remaining in the track were
small and had no outgrowth of cell processes, indicating they
were still in an immature neuroprogenitor state. A similar
condition was reported even at 3 weeks after transplantation
in a study using hESC-derived NPCs grafted into mouse
brain23. The fate of these immature cells may depend on
their phenotype and their opportunity to integrate with host
tissue, since there were few surviving cells in the graft track
3 weeks after transplantation.
We identified two distinct morphological patterns of fiber
outgrowth and distribution in both jj and Nj brains. One
pattern was characterized by short and thick parallel fibers,
which usually had cell bodies nearby. This pattern was
observed in most of the grafted brains and was very easy
to recognize along the host-injection tract interface. This
Figure 7. PENK expression in host brain. IHC revealed strong PENK expression in MGE-like NPC grafts, included glia and connecting
fibers, at or near the graft site in the host brain. (a–d): 3 days post-transplantation in the striatum. PENK-expressing astrocytes surrounded
the graft track. There was a zone of low PENK expression between the graft and the surrounding PENK-expressing astrocytes. (e–h): 10
days post-transplantation in the GP. The graft was located between the GP and ic (note that PENK fibers extended from the GP toward the
region containing surviving graft cells and fibers). There were also PENK-expressing astrocytes near the graft site. (i–l): 3 weeks post-
transplantation in the GP. In this plane, the actual graft location was between the ic and thalamus. Note the PENK-expressing astrocytes
were dorsomedial to the graft, included a large area of the thalamus. (a, e, i): lower magnification to show the location of graft and area
containing PENK-expressing cells and fibers. Scale bar: (a), 500 mm, (e, i), 200 mm; all the others 100 mm. Arrows point to graft location,
PENK-expressing host cells, fibers, and regions. GP: globus pallidus; ic: internal capsule; IHC: immunohistochemistry; MGE: medial ganglionic
eminence; NPC: neural progenitor cell; PENK: proenkephalin; str: striatum.
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type of fiber arrangement resembled the dendrites of PV
neurons in the GP7, which receive PENK projections from
striatal medium spiny neurons. Further investigation is nec-
essary to test whether our fibers share this phenotype.
Another frequently observed pattern was a population of
medial and ventral-directed long axons, which projected to
the thalamus or regions ventral to the thalamus. Since these
areas are the targets, or pass-through sites to the targets, of
GP output pathways7,15, it may be that the grafted neurons
formed normal GP efferent fibers projecting to multiple tar-
gets. Interestingly, long fibers projecting to the striatum,
another destination of the GP circuit8, were not found. It was
reported that GP neurons were dichotomous: those GP
neurons projecting to the thalamus, subthalamic nucleus
(STN), or substantia nigra (SN) were PV-positive prototypic
GABAergic neurons, while the projections to the striatum
were from PENK-positive arkypallidal neurons8,15. Our
observations suggest one of two possibilities: either the
grafted cells had not differentiated enough to represent cer-
tain GP cell types, or some types of grafted cells did not
adapt to the host environment and thus did not survive.
Although numerous PV-ir cells were co-labeled with
GAD-6 in culture, few MGE-like NPCs expressed PV after
transplantation. The ones that did remained in the Matrigel
of the injection tract. One possibility is that the development
of these cells was delayed after grafting and did not express
the more mature phenotypic marker within our time frames.
A similar outcome was reported in another stem cell trans-
plantation study in a rat model of Huntington’s disease24.
However, this could also suggest that some PV-ir cells may
have down-regulated PV expression when they migrated into
host tissue. Because PV-ir neurons are the largest cell type in
the GP7,15 and they are decreased in kernicterus25, improving
grafted PV neuronal survival and function will be important
for stem cell therapy in kernicterus.
Despite a large number of PENK-ir cells in culture,
PENK-ir cells were not found in either jj or Nj brain. This
population of cells may not have survived or may have lost
their PENK phenotype after transplantation. We did, how-
ever, observe PENK-ir fibers (Figure 7) extending from the
host GP to the graft. These fibers should be axon collaterals
from striatal PENK-ir medium spiny neurons, which nor-
mally synapse with GP neurons16. This result suggests that
MGE-like NPC grafts may attract striatal medium spiny
neuron collateral fibers growing toward it, which is vital for
reconstructing impaired circuits. Surprisingly, the grafts
induced strong PENK expression near every graft site of the
host brain. Their shape suggests that these PENK-ir cells
could be astrocytes. The aggregation and over-expressing
of PENK in host astrocytes has not been documented previ-
ously. A role for PENK in astrocytes has been proposed for
modulating brain development and maturation26,27. Because
PENK has been considered to be a negative trophic regulator
for neuronal proliferation and differentiation, the interaction
between the PENK-expressing astrocytes and opioid
receptor-expressing neurons may be a mechanism for
affecting growth and migration of these neurons26. The
PENK-hyper-expressing astrocytes that we observed could
be guiding the graft cells. Further research is necessary to
test this hypothesis.
In conclusion, the present study demonstrated hESC-
derived MGE-like NPCs were able to survive and generate
abundant and diverse fiber types within a short period after
being transplanted into jj or Nj rat brain. These grafted cells
have the potential to form circuits between the GP and its
connecting nuclei. It will be necessary to extend our time-
points to determine synaptic formation and other aspects of
NPC development23. The graft survival rate was greater in jj
than in Nj rats, which could due to the slightly elevated
bilirubin concentration in the jj brain. The overall cell survi-
vability was low however, indicating immunosuppressant
may be necessary to increase graft survival. In addition,
compared with other studies23,24, the total number of cells
injected was low in our experiment. Increasing the injected
cell number could increase the number of surviving cells in
future studies. Because we only focused on the anatomical
aspects of cell survival and development in jaundiced rats,
future studies are required to examine functional recovery in
dystonic rats and to explore underlying mechanisms of
recovery.
Various types of stem cells have been widely tested in
many animal models of Parkinson’s disease28,29, Hunting-
ton’s disease24,30, and other neurological conditions that
affect motor function31,32. To our knowledge, there have
been no preclinical studies in which stem cells were trans-
planted into the GP to treat dystonia. There have also been no
studies reporting NPCs specifically designed to differentiate
into GP neurons. The results of this research suggest the
possibility of using hESC-derived MGE-like NPCs for
repairing GP neurons. With further optimization of the dif-
ferentiation protocol, these cells hold promise for use in
restoring basal ganglia circuits in kernicterus.
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